Hot Features
Propanc Biopharma, Inc., a development-stage biopharmaceutical healthcare company, engages in the development of cancer treatments for patients with pancreatic, ovarian, and colorectal cancers in Australia. Its lead product candidate is PRP, an intravenous injection proenzyme treatment designed as a... Propanc Biopharma, Inc., a development-stage biopharmaceutical healthcare company, engages in the development of cancer treatments for patients with pancreatic, ovarian, and colorectal cancers in Australia. Its lead product candidate is PRP, an intravenous injection proenzyme treatment designed as a therapeutic option in cancer treatment and prevention which has completed pre-clinical studies. The company has a research and collaboration agreement with the University of Jaén, to undertakes the research activities for the POP1 Program and the University of Granada to develop a synthetic recombinant version of PRP. Propanc Biopharma, Inc. was formerly known as Propanc Health Group Corporation and changed its name to Propanc Biopharma, Inc. in April 2017. The company was incorporated in 2007 and is based in Camberwell, Australia. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.25 | 14.880952381 | 1.68 | 6.79 | 1.3 | 34902617 | 2.4293401 | CS |
| 4 | 1.858 | 2580.55555556 | 0.072 | 6.79 | 0.0635 | 9415390 | 2.38078965 | CS |
| 12 | 1.8112 | 1524.57912458 | 0.1188 | 6.79 | 0.0635 | 5818372 | 1.31372861 | CS |
| 26 | 1.123 | 139.157372986 | 0.807 | 6.79 | 0.0635 | 3605104 | 1.04143799 | CS |
| 52 | -3.87 | -66.724137931 | 5.8 | 9.36 | 0.0635 | 2780833 | 1.81850046 | CS |
| 156 | -3.87 | -66.724137931 | 5.8 | 9.36 | 0.0635 | 2780833 | 1.81850046 | CS |
| 260 | -3.87 | -66.724137931 | 5.8 | 9.36 | 0.0635 | 2780833 | 1.81850046 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.